1,001 results

1. pTR-UF11 (AAV.A09.T)

   Viral Prep

   #157970-AAV.A09.T

   Purpose

   Ready-to-use AAV6 in TMN200 particles produced from pTR-UF11 (#157970). In addition to the viral particles, you will also receive purified pTR-UF11 plasmid DNA. 'Humanized' GFP driven by Chimeric CMV/Chicken Beta Actin promoter

   Depositor

   Sergei Zolotukhin

   Article

   Burger et al Mol Ther. 2004 Aug;10(2):302-17. doi: 10

   Promoter

   chimeric CMV/Chicken Beta actin (CBA)

   Tags

   GFP

   Available since

   Dec. 21, 2020

   Availability

   Academic Institutions and Nonprofits only

2. AAV-EF1a-jGCaMP8f-WPRE (AAV1)

   Viral Prep

   #176756-AAV1

   Purpose

   Ready-to-use AAV1 particles produced from AAV-EF1a-jGCaMP8f-WPRE (#176756). In addition to the viral particles, you will also receive purified AAV-EF1a-jGCaMP8f-WPRE plasmid DNA. EF1a-driven expression of calcium sensor GCaMP8f. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Loren Looger

   Promoter

   EF1a

   Tags

   None

   Available since

   Feb. 24, 2023

   Availability

   Academic Institutions and Nonprofits only

3. pAAV-Ef1a-DIO C1V1 (t/t)-TS-EYFP (AAV9)

   Viral Prep

   #35497-AAV9

   Purpose

   Ready-to-use AAV9 particles produced from pAAV-Ef1a-DIO C1V1 (t/t)-TS-EYFP (#35497). In addition to the viral particles, you will also receive purified pAAV-Ef1a-DIO C1V1 (t/t)-TS-EYFP plasmid DNA. EFIa-driven, Cre-dependent, C1V1 (t/t) fused to EYFP for optogenetic activation. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Karl Deisseroth

   Article

   Yizhar et al Nature. 2011 Jul 27;477(7363):171-8. doi

   Promoter

   EF1a

   Tags

   EYFP (Cre-dependent)

   Available since

   March 30, 2018

   Availability

   Academic Institutions and Nonprofits only

4. pAAV.CMV.LacZ.bGH (AAV8)

   Viral Prep

   #105531-AAV8

   Purpose

   Ready-to-use AAV8 particles produced from pAAV.CMV.LacZ.bGH (#105531). In addition to the viral particles, you will also receive purified pAAV.CMV.LacZ.bGH plasmid DNA. CMV-driven LacZ expression control. These AAV preparations are suitable purity for injection into animals.

   Depositor

   James M. Wilson

   Promoter

   CMV

   Tags

   LacZ

   Available since

   June 29, 2018

   Availability

   Academic Institutions and Nonprofits only

5. pENN.AAV.CMVs.TurboRFP.WPRE.RBG (AAV8)

   Viral Prep

   #105548-AAV8

   Purpose

   Ready-to-use AAV8 particles produced from pENN.AAV.CMVs.TurboRFP.WPRE.RBG (#105548). In addition to the viral particles, you will also receive purified pENN.AAV.CMVs.TurboRFP.WPRE.RBG plasmid DNA. CMV-driven TurboRFP expression. These AAV preparations are suitable purity for injection into animals.

   Depositor

   James M. Wilson

   Promoter

   CMV

   Tags

   TurboRFP

   Available since

   June 29, 2018

   Availability

   Academic Institutions and Nonprofits only

6. pAAV-syn-FLEX-jYCaMP1s (AAV1)

   Viral Prep

   #135420-AAV1

   Purpose

   Ready-to-use AAV1 particles produced from pAAV-syn-FLEX-jYCaMP1s (#135420). In addition to the viral particles, you will also receive purified pAAV-syn-FLEX-jYCaMP1s plasmid DNA. Synapsin-driven, Cre-dependent expression of calcium sensor YCaMP1s. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Kaspar Podgorski

   Article

   Mohr et al Nat Methods. 2020 May 25. pii: 10.1038/s

   Promoter

   Syn

   Tags

   None

   Available since

   July 31, 2020

   Availability

   Academic Institutions and Nonprofits only

7. pAAV-hSynapsin1-axon-jGCaMP8f-P2A-mRuby3 (AAV1)

   Viral Prep

   #172923-AAV1

   Purpose

   Ready-to-use AAV1 particles produced from pAAV-hSynapsin1-axon-jGCaMP8f-P2A-mRuby3 (#172923). In addition to the viral particles, you will also receive purified pAAV-hSynapsin1-axon-jGCaMP8f-P2A-mRuby3 plasmid DNA. hSyn-driven expression of jGCaMP8f in axons with cytosolic expression of mRuby3. These AAV preparations are suitable purity for injection into animals.

   Depositor

   GENIE Project

   Promoter

   Syn

   Tags

   mRuby3

   Available since

   June 8, 2023

   Availability

   Academic Institutions and Nonprofits only

8. AiP13863 - pAAV-AiE0888m_C4-minBG-SYFP2-WPRE3-BGHpA (Alias: CN3863) (AAV PHP.eB)

   Viral Prep

   #199773-PHPeB

   Purpose

   Ready-to-use AAV PHP.eB particles produced from AiP13863 - pAAV-AiE0888m_C4-minBG-SYFP2-WPRE3-BGHpA (Alias: CN3863) (#199773). In addition to the viral particles, you will also receive purified AiP13863 - pAAV-AiE0888m_C4-minBG-SYFP2-WPRE3-BGHpA (Alias: CN3863) plasmid DNA. SYFP2 expression in midbrain dopamine neurons. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.

   Depositor

   The Allen Institute for Brain Science, Jonathan Ting

   Article

   Hunker et al Neuron. 2025 May 21;113(10):1507-1524.e1

   Promoter

   Tags

   SYFP2

   Available since

   July 15, 2024

   Availability

   Academic Institutions and Nonprofits only

9. pAAV-CaMKIIa-ChRmine-oScarlet-KV 2.1-WPRE (AAV8)

   Viral Prep

   #183519-AAV8

   Purpose

   Ready-to-use AAV8 particles produced from pAAV-CaMKIIa-ChRmine-oScarlet-KV 2.1-WPRE (#183519). In addition to the viral particles, you will also receive purified pAAV-CaMKIIa-ChRmine-oScarlet-KV 2.1-WPRE plasmid DNA. CaMKIIa-driven expression of ChRmine-oScarlet-KV 2.1. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Karl Deisseroth

   Article

   Kishi et al Cell. 2022 Feb 17;185(4):672-689.e23. do

   Promoter

   CaMKII

   Tags

   None

   Available since

   Dec. 18, 2024

   Availability

   Academic Institutions and Nonprofits only

10. pAAV-Ef1a-oScarlet (AAV8)

    Viral Prep

    #137135-AAV8

    Purpose

    Ready-to-use AAV8 particles produced from pAAV-Ef1a-oScarlet (#137135). In addition to the viral particles, you will also receive purified pAAV-Ef1a-oScarlet plasmid DNA. EF1a-driven expression of oScarlet. These AAV preparations are suitable purity for injection into animals.

    Depositor

    INTRSECT 2.0 Project, Karl Deisseroth

    Article

    Fenno et al Neuron. 2020 Jun 20. pii: S0896-6273(20)

    Promoter

    EF1a

    Tags

    oScarlet

    Available since

    May 6, 2021

    Availability

    Academic Institutions and Nonprofits only